BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31186096)

  • 1. [Subcutaneous botulinum toxin in the treatment of peripheral neuropathic pain].
    Puentes Gutiérrez AB; García Bascones M; Puentes Gutiérrez R; Díaz Jiménez M
    Rehabilitacion (Madr); 2019; 53(2):131-135. PubMed ID: 31186096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
    Attal N; de Andrade DC; Adam F; Ranoux D; Teixeira MJ; Galhardoni R; Raicher I; Üçeyler N; Sommer C; Bouhassira D
    Lancet Neurol; 2016 May; 15(6):555-65. PubMed ID: 26947719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of subcutaneous injection of botulinum toxin A on spinal cord injury-associated neuropathic pain.
    Han ZA; Song DH; Chung ME
    Spinal Cord; 2014 Jun; 52 Suppl 1():S5-6. PubMed ID: 24902645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous botulinum toxin for chronic post-thoracotomy pain.
    Fabregat G; Asensio-Samper JM; Palmisani S; Villanueva-Pérez VL; De Andrés J
    Pain Pract; 2013 Mar; 13(3):231-4. PubMed ID: 22716282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin in trigeminal neuralgia.
    Castillo-Álvarez F; Hernando de la Bárcena I; Marzo-Sola ME
    Med Clin (Barc); 2017 Jan; 148(1):28-32. PubMed ID: 27743594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.
    Han ZA; Song DH; Oh HM; Chung ME
    Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Notalgia paresthetica: Treatment with botulinum toxin type A].
    Morcillo Pérez C; Guerras Normand I; García Chinchetru MC
    Rehabilitacion (Madr); 2020; 54(2):142-145. PubMed ID: 32370829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous and perineural botulinum toxin type a for neuropathic pain: a descriptive review.
    Fabregat G; De Andrés J; Villanueva-Pérez VL; Asensio-Samper JM
    Clin J Pain; 2013 Nov; 29(11):1006-12. PubMed ID: 23370086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous botulinum toxin-A injection for treating postherpetic neuralgia.
    Hu Y; Zou L; Qi X; Lu Y; Zhou X; Mao Z; Chen X; Liu K; Yang Y; Wu Z; Hu Y; Ma S
    Dermatol Ther; 2020 Jan; 33(1):e13181. PubMed ID: 31769900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C; Díaz S; Piedimonte F; Micheli F
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):500-3. PubMed ID: 18813708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineural injection of botulinum toxin-A in painful peripheral nerve injury - a case series: pain relief, safety, sensory profile and sample size recommendation.
    Meyer-Frießem CH; Eitner LB; Kaisler M; Maier C; Vollert J; Westermann A; Zahn PK; Avila González CA
    Curr Med Res Opin; 2019 Oct; 35(10):1793-1803. PubMed ID: 31148462
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
    Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
    Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D; Attal N; Morain F; Bouhassira D
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin a improved burning pain and allodynia in two patients with spinal cord pathology.
    Jabbari B; Maher N; Difazio MP
    Pain Med; 2003 Jun; 4(2):206-10. PubMed ID: 12873271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin - intraorally: Intraoral administration of botulinum toxin for trigeminal neuropathic pain.
    Br Dent J; 2016 Aug; 221(3):126. PubMed ID: 27514346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin Type-A (Botulax
    Kim H; Jang B; Kim ST
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34064451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous Botulinum Toxin Injection for Post-Thoracotomy Pain Syndrome in Palliative Care: A Case Report.
    Rashid S; Fields AR; Baumrucker SJ
    Am J Hosp Palliat Care; 2018 Mar; 35(3):511-513. PubMed ID: 28641445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury.
    Li G; Lv CA; Tian L; Jin LJ; Sun P; Zhao W
    Medicine (Baltimore); 2017 May; 96(20):e6919. PubMed ID: 28514309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new target for the treatment of trigeminal neuralgia with botulinum toxin type A.
    Wu C; Xie N; Liu H; Zhang H; Zhang L; Lian Y
    Neurol Sci; 2018 Mar; 39(3):599-602. PubMed ID: 29086125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Battling Neuropathic Scar Pain With Botulinum Toxin.
    Schuler A; Veenstra J; Ozog D
    J Drugs Dermatol; 2019 Sep; 18(9):937-938. PubMed ID: 31524351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.